# Coda Octopus Group, Inc.: financial statements, quarterly

CODA · Nasdaq · CIK 1334325 · [Technology](/sectors/technology.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/coda.md) · [Financials](/companies/coda/financials.md) · [Filings](/companies/coda/filings.md) · [Insiders](/companies/coda/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/coda/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,564 d](/filings/0001493152-25-004075.md) | [4,461](/filings/0001493152-25-010461.md) | [5,323](/filings/0001641172-25-015171.md) | [5,477](/filings/0001493152-25-013374.md) | [5,055 d](/filings/0001493152-26-008174.md) | [5,210](/filings/0001493152-26-010399.md) | [7,017](/filings/0001493152-26-028609.md) | [7,065](/filings/0001493152-26-042475.md) | [7,271 d](/filings/0001493152-26-008174.md) | [6,710](/filings/0001493152-26-010399.md) | [6,904](/filings/0001493152-26-028609.md) | [7,717](/filings/0001493152-26-042475.md) |
| Cost of revenue | $k | [1,274 d](/filings/0001493152-25-004075.md) | [1,374](/filings/0001493152-25-010461.md) | [1,585](/filings/0001641172-25-015171.md) | [1,428](/filings/0001493152-25-013374.md) | [1,756 d](/filings/0001493152-26-008174.md) | [1,781](/filings/0001493152-26-010399.md) | [2,520](/filings/0001493152-26-028609.md) | [2,241](/filings/0001493152-26-042475.md) | [2,358 d](/filings/0001493152-26-008174.md) | [2,343](/filings/0001493152-26-010399.md) | [2,326](/filings/0001493152-26-028609.md) | [2,667](/filings/0001493152-26-042475.md) |
| Gross profit | $k | [2,290 d](/filings/0001493152-25-004075.md) | [3,087](/filings/0001493152-25-010461.md) | [3,738](/filings/0001641172-25-015171.md) | [4,049](/filings/0001493152-25-013374.md) | [3,299 d](/filings/0001493152-26-008174.md) | [3,428](/filings/0001493152-26-010399.md) | [4,497](/filings/0001493152-26-028609.md) | [4,824](/filings/0001493152-26-042475.md) | [4,913 d](/filings/0001493152-26-008174.md) | [4,367](/filings/0001493152-26-010399.md) | [4,578](/filings/0001493152-26-028609.md) | [5,050](/filings/0001493152-26-042475.md) |
| Research and development | $k | [558 d](/filings/0001493152-25-004075.md) | [486](/filings/0001493152-25-010461.md) | [542](/filings/0001641172-25-015171.md) | [496](/filings/0001493152-25-013374.md) | [718 d](/filings/0001493152-26-008174.md) | [543](/filings/0001493152-26-010399.md) | [690](/filings/0001493152-26-028609.md) | [572](/filings/0001493152-26-042475.md) | [642 d](/filings/0001493152-26-008174.md) | [606](/filings/0001493152-26-010399.md) | [648](/filings/0001493152-26-028609.md) | [729](/filings/0001493152-26-042475.md) |
| Selling, general and administrative | $k | [2,056 d](/filings/0001493152-25-004075.md) | [2,045](/filings/0001493152-25-010461.md) | [1,846](/filings/0001641172-25-015171.md) | [2,161](/filings/0001493152-25-013374.md) | [2,294 d](/filings/0001493152-26-008174.md) | [2,223](/filings/0001493152-26-010399.md) | [2,720](/filings/0001493152-26-028609.md) | [2,871](/filings/0001493152-26-042475.md) | [2,864 d](/filings/0001493152-26-008174.md) | [2,751](/filings/0001493152-26-010399.md) | [2,137](/filings/0001493152-26-028609.md) | [2,788](/filings/0001493152-26-042475.md) |
| Operating income | $k | [(324) d](/filings/0001493152-25-004075.md) | [555](/filings/0001493152-25-010461.md) | [1,350](/filings/0001641172-25-015171.md) | [1,391](/filings/0001493152-25-013374.md) | [288 d](/filings/0001493152-26-008174.md) | [662](/filings/0001493152-26-010399.md) | [1,088](/filings/0001493152-26-028609.md) | [1,380](/filings/0001493152-26-042475.md) | [1,406 d](/filings/0001493152-26-008174.md) | [1,010](/filings/0001493152-26-010399.md) | [1,793](/filings/0001493152-26-028609.md) | [1,533](/filings/0001493152-26-042475.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [275 d](/filings/0001493152-25-004075.md) | [153](/filings/0001493152-25-010461.md) | [226](/filings/0001641172-25-015171.md) | [357](/filings/0001493152-25-013374.md) | [230 d](/filings/0001493152-26-008174.md) | [21.9](/filings/0001493152-26-010399.md) | [357](/filings/0001493152-26-028609.md) | [261](/filings/0001493152-26-042475.md) | [743 d](/filings/0001493152-26-008174.md) | [256](/filings/0001493152-26-010399.md) | [436](/filings/0001493152-26-028609.md) | [402](/filings/0001493152-26-042475.md) |
| Net income | $k | [(321) d](/filings/0001493152-25-004075.md) | [630](/filings/0001493152-25-013374.md) | [1,415](/filings/0001493152-25-013374.md) | [1,275](/filings/0001493152-25-013374.md) | [326 d](/filings/0001493152-26-008174.md) | [913](/filings/0001493152-26-042475.md) | [909](/filings/0001493152-26-042475.md) | [1,283](/filings/0001493152-26-042475.md) | [1,025 d](/filings/0001493152-26-008174.md) | [931](/filings/0001493152-26-042475.md) | [1,698](/filings/0001493152-26-042475.md) | [1,390](/filings/0001493152-26-042475.md) |
| Diluted EPS | $ per share | not reported | [0.06](/filings/0001493152-25-010461.md) | [0.13](/filings/0001641172-25-015171.md) | [0.11](/filings/0001493152-25-013374.md) | not reported | [0.08](/filings/0001493152-26-010399.md) | [0.08](/filings/0001493152-26-028609.md) | [0.11](/filings/0001493152-26-042475.md) | not reported | [0.08](/filings/0001493152-26-010399.md) | [0.15](/filings/0001493152-26-028609.md) | [0.12](/filings/0001493152-26-042475.md) |
| Basic EPS | $ per share | not reported | [0.06](/filings/0001493152-25-010461.md) | [0.13](/filings/0001641172-25-015171.md) | [0.11](/filings/0001493152-25-013374.md) | not reported | [0.08](/filings/0001493152-26-010399.md) | [0.08](/filings/0001493152-26-028609.md) | [0.11](/filings/0001493152-26-042475.md) | not reported | [0.08](/filings/0001493152-26-010399.md) | [0.15](/filings/0001493152-26-028609.md) | [0.12](/filings/0001493152-26-042475.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [24.4](/filings/0001493152-25-004075.md) | [25.0](/filings/0001493152-24-010216.md) | [23.7](/filings/0001493152-24-023544.md) | [25.2](/filings/0001493152-24-036298.md) | [22.5](/filings/0001493152-26-008174.md) | [22.5](/filings/0001493152-25-010461.md) | [24.5](/filings/0001641172-25-015171.md) | [26.2](/filings/0001493152-25-013374.md) | [28.7](/filings/0001493152-26-042475.md) | [30.4](/filings/0001493152-26-010399.md) | [30.6](/filings/0001493152-26-028609.md) | [31.7](/filings/0001493152-26-042475.md) |
| Current assets | $m | [40.9](/filings/0001493152-25-004075.md) | [42.8](/filings/0001493152-24-010216.md) | [43.8](/filings/0001493152-24-023544.md) | [45.7](/filings/0001493152-24-036298.md) | [43.0](/filings/0001493152-26-008174.md) | [42.7](/filings/0001493152-25-010461.md) | [46.3](/filings/0001641172-25-015171.md) | [47.4](/filings/0001493152-25-013374.md) | [50.0](/filings/0001493152-26-042475.md) | [51.2](/filings/0001493152-26-010399.md) | [52.9](/filings/0001493152-26-028609.md) | [54.6](/filings/0001493152-26-042475.md) |
| Total assets | $m | [51.8](/filings/0001493152-25-004075.md) | [53.0](/filings/0001493152-24-010216.md) | [54.0](/filings/0001493152-24-023544.md) | [55.9](/filings/0001493152-24-036298.md) | [57.5](/filings/0001493152-26-008174.md) | [56.9](/filings/0001493152-25-010461.md) | [60.6](/filings/0001641172-25-015171.md) | [61.9](/filings/0001493152-25-013374.md) | [64.5](/filings/0001493152-26-042475.md) | [65.6](/filings/0001493152-26-010399.md) | [67.3](/filings/0001493152-26-028609.md) | [68.9](/filings/0001493152-26-042475.md) |
| Current liabilities | $m | [3.3](/filings/0001493152-25-004075.md) | [2.8](/filings/0001493152-24-010216.md) | [2.8](/filings/0001493152-24-023544.md) | [3.0](/filings/0001493152-24-036298.md) | [3.9](/filings/0001493152-26-008174.md) | [3.3](/filings/0001493152-25-010461.md) | [4.2](/filings/0001641172-25-015171.md) | [4.2](/filings/0001493152-25-013374.md) | [5.6](/filings/0001493152-26-042475.md) | [4.7](/filings/0001493152-26-010399.md) | [5.2](/filings/0001493152-26-028609.md) | [5.4](/filings/0001493152-26-042475.md) |
| Total liabilities | $m | [3.4](/filings/0001493152-25-004075.md) | [2.9](/filings/0001493152-24-010216.md) | [2.9](/filings/0001493152-24-023544.md) | [3.1](/filings/0001493152-24-036298.md) | [4.4](/filings/0001493152-26-008174.md) | [3.8](/filings/0001493152-25-010461.md) | [4.7](/filings/0001641172-25-015171.md) | [4.6](/filings/0001493152-25-013374.md) | [6.4](/filings/0001493152-26-042475.md) | [5.4](/filings/0001493152-26-010399.md) | [5.9](/filings/0001493152-26-028609.md) | [6.1](/filings/0001493152-26-042475.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [48.4](/filings/0001493152-26-008174.md) | [50.1](/filings/0001493152-25-013374.md) | [51.1](/filings/0001493152-25-013374.md) | [52.8](/filings/0001493152-25-013374.md) | [53.1](/filings/0001493152-26-042475.md) | [53.1](/filings/0001493152-26-042475.md) | [55.9](/filings/0001493152-26-042475.md) | [57.3](/filings/0001493152-26-042475.md) | [58.1](/filings/0001493152-26-042475.md) | [60.2](/filings/0001493152-26-042475.md) | [61.4](/filings/0001493152-26-042475.md) | [62.7](/filings/0001493152-26-042475.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,005 d](/filings/0001493152-25-004075.md) | [(298)](/filings/0001493152-25-010461.md) | [(956) d](/filings/0001641172-25-015171.md) | [1,712 d](/filings/0001493152-25-013374.md) | [1,994 d](/filings/0001493152-26-008174.md) | [642](/filings/0001493152-26-010399.md) | [1,462 d](/filings/0001493152-26-028609.md) | [2,204 d](/filings/0001493152-26-042475.md) | [2,903 d](/filings/0001493152-26-008174.md) | [1,477](/filings/0001493152-26-010399.md) | [570 d](/filings/0001493152-26-028609.md) | [1,383 d](/filings/0001493152-26-042475.md) |
| Capital expenditure | $k | [1,589 d](/filings/0001493152-25-004075.md) | [136](/filings/0001493152-25-010461.md) | [155 d](/filings/0001641172-25-015171.md) | [165 d](/filings/0001493152-25-013374.md) | [47.4 d](/filings/0001493152-26-008174.md) | [128](/filings/0001493152-26-010399.md) | [68.2 d](/filings/0001493152-26-028609.md) | [609 d](/filings/0001493152-26-042475.md) | [365 d](/filings/0001493152-26-008174.md) | [82.2](/filings/0001493152-26-010399.md) | [121 d](/filings/0001493152-26-028609.md) | [162 d](/filings/0001493152-26-042475.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-31) | Q2 FY2023 (2023-04-30) | Q3 FY2023 (2023-07-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.4](/filings/0001493152-24-010216.md) | [11.3](/filings/0001493152-24-023544.md) | [11.3](/filings/0001493152-24-036298.md) | [11.3](/filings/0001493152-25-010461.md) | [11.3](/filings/0001641172-25-015171.md) | [11.3](/filings/0001493152-25-013374.md) | [11.3](/filings/0001493152-26-010399.md) | [11.3](/filings/0001493152-26-028609.md) | [11.3](/filings/0001493152-26-042475.md) | [11.3](/filings/0001493152-26-010399.md) | [11.3](/filings/0001493152-26-028609.md) | [11.3](/filings/0001493152-26-042475.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,283,101 at 2026-09-14, from the cover of the [10-Q filed 2026-09-14](/filings/0001493152-26-042475.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.